SCHEMBL9979919

SCHEMBL9979919

Cn1c2ccc(-c3cccs3)cc2c2cc3c(cc21)c1cc(-c2cccs2)ccc1n3C

nearest known ligand 0.51

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ NR4A2 P43354 1/20 0.51
▸ KCNH2 Q12809 1/20 0.46
▸ L3MBTL1 Q9Y468 3/20 0.44
▸ HTR1D P28221 5/20 0.43
▸ HTR1B P28222 5/20 0.43
▸ MAOA P21397 1/20 0.42
▸ CD38 P28907 1/20 0.42
▸ CHEK1 O14757 1/20 0.40
▸ ERN1 O75460 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ PRMT6 Q96LA8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14153340 0.98 NR4A2 (0.50) NR4A2KCNH2L3MBTL1HTR1DHTR1B
SCHEMBL9979918 0.90 NR4A2 (0.43) NR4A2KCNH2L3MBTL1HTR1DHTR1B
SCHEMBL20987442 0.85 NR4A2 (0.46) NR4A2L3MBTL1CD38CHEK1KDM4E
SCHEMBL15747195 0.83 KDM4E (0.44) NR4A2KDM4EALDH1A1
SCHEMBL12943080 0.81 NR4A2 (0.38) NR4A2KCNH2L3MBTL1HTR1DHTR1B
SCHEMBL20987436 0.77 CNR2 (0.47) NR4A2KDM4EALDH1A1
SCHEMBL28215696 0.77 NR4A2 (0.46) NR4A2KCNH2HTR1DHTR1BKDM4E
SCHEMBL31223938 0.76 NR4A2 (0.46) NR4A2KCNH2L3MBTL1CD38CHEK1
SCHEMBL925258 0.76 KDM4E (0.47) NR4A2KDM4EALDH1A1
SCHEMBL27964962 0.75 KDM4E (0.46) NR4A2KCNH2L3MBTL1HTR1DHTR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120157689-A1 SUBSTITUTED INDOLOCARBAZOLES XEROX CORPORATION (US) 2012-06-21 — — US disclosed
US-8110690-B2 Substituted indolocarbazoles XEROX CORPORATION (US) 2012-02-07 — — US disclosed
US-8003807-B2 organic thin film transistor with a semiconductor layer including the small molecule having didodecylindolo[3,2-b]carbazole groups XEROX CORPORATION (US) 2011-08-23 — — US disclosed
US-7829727-B2 Device containing compound having indolocarbazole moiety and divalent linkage XEROX CORPORATION (US) 2010-11-09 — — US disclosed
US-20100230670-A1 DEVICE CONTAINING COMPOUND HAVING INDOLOCARBAZOLE MOIETY AND DIVALENT LINKAGE XEROX CORPORATION (US) 2010-09-16 — — US disclosed
US-7528261-B2 Small molecule compound having indolocarbazole moiety and divalent linkage XEROX CORPORATION (US) 2009-05-05 — — US disclosed
US-20090036689-A1 SUBSTITUTED INDOLOCARBAZOLES XEROX CORPORATION (US) 2009-02-05 — — US disclosed
US-7456424-B2 Thin film transistors including indolocarbozoles XEROX CORPORATION (US) 2008-11-25 — — US disclosed
US-20080207917-A1 POLYMER HAVING INDOLOCARBAZOLE MOIETY AND DIVALENT LINKAGE XEROX CORPORATION (US) 2008-08-28 — — US disclosed
US-7396852-B2 Compound having indolocarbazole moiety and divalent linkage XEROX CORPORATION (US) 2008-07-08 — — US disclosed
US-20080103314-A1 SMALL MOLECULE COMPOUND HAVING INDOLOCARBAZOLE MOIETY AND DIVALENT LINKAGE XEROX CORPORATION (US) 2008-05-01 — — US disclosed
US-20070112167-A1 Device containing compound having indolocarbazole moiety and divalent linkage XEROX CORPORATION 2007-05-17 — — US disclosed
US-20070112172-A1 Compound having indolocarbazole moiety and divalent linkage XEROX CORPORATION 2007-05-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090036689-A1 SUBSTITUTED INDOLOCARBAZOLES HTR3C, HTR3A, AANAT NR4A2 1210/4885KCNH2 2236/4885L3MBTL1 1311/4885
US-20070112172-A1 Compound having indolocarbazole moiety and divalent linkage INMT, IDO2, GRIN2C NR4A2 1476/4885KCNH2 619/4885L3MBTL1 2177/4885
US-20080103314-A1 SMALL MOLECULE COMPOUND HAVING INDOLOCARBAZOLE MOIETY AND DIVALENT LINKAGE SLC43A1, SLC7A5, KCNN2 NR4A2 2187/4885KCNH2 935/4885L3MBTL1 3134/4885
US-20100230670-A1 DEVICE CONTAINING COMPOUND HAVING INDOLOCARBAZOLE MOIETY AND DIVALENT LINKAGE BRD4, BICRA, INMT NR4A2 1948/4885KCNH2 75/4885L3MBTL1 1990/4885
US-20080207917-A1 POLYMER HAVING INDOLOCARBAZOLE MOIETY AND DIVALENT LINKAGE SGTA, MTCL3, SMC3 NR4A2 2869/4885KCNH2 2585/4885L3MBTL1 1538/4885
US-20120157689-A1 SUBSTITUTED INDOLOCARBAZOLES HTR3C, HTR3A, AANAT NR4A2 1210/4885KCNH2 2236/4885L3MBTL1 1311/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback